Recruiting Lymphoma Studies in Canton
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
This phase 2 trial studies the side effects and best dose of tazemetostat and zanubrutinib in combination with tafasitamab and lenalidomide, and to see how well these combinations work in treating pat...
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) ...
About Lymphoma Clinical Trials in Canton
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Canton, MICHIGAN. These studies are seeking a combined 371 participants. Research is being sponsored by SWOG Cancer Research Network, AVM Biotechnology Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Canton — FAQ
Are there lymphoma clinical trials in Canton?
Yes, there are 2 lymphoma clinical trials currently recruiting in Canton, MICHIGAN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Canton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Canton research site will contact you about next steps.
Are clinical trials in Canton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Canton studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Canton are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov